CEACAMP10: A Potential Drug Target and Biomarker (G1098)

Target Name: CEACAMP10

NCBI ID: G1098

CEACAMP10

Other Name(s): Carcinoembryonic antigen-related cell adhesion molecule pseudogene 10 | CEACAM31P | CEA cell adhesion molecule pseudogene 10 | CGM17

CEACAMP10: A Potential Drug Target and Biomarker

Cell adhesion molecules (CAMs) are a family of transmembrane proteins that play a crucial role in various physiological processes, including tissue repair, regeneration, and cancer progression. CEACAMP10, also known as Carcinoembryonic antigen-related cell adhesion molecule pseudogene 10, is a non-coding RNA molecule that belongs to the CEACAMP10 gene family. In this article, we will discuss CEACAMP10 as a potential drug target and biomarker, focusing on its structure, function, and potential therapeutic applications.

Structure and Function

CEACAMP10 is a small non-coding RNA molecule that is expressed in various tissues and cells, including epithelial, neural, and liver cells. It has a length of approximately 240 nucleotides and is composed of 11 exons. The CEACAMP10 protein is a cytoplasmic protein that is primarily localized to the endoplasmic reticulum (ER) and is involved in the regulation of cell adhesion and migration.

CEACAMP10 functions as a cell adhesion molecule by interacting with various cell surface molecules, including cadherins, n cadherins, and vimentin. These interactions are essential for the formation of tight junctions, which are critical for maintaining tissue structure and function. Additionally, CEACAMP10 has been shown to regulate the expression of adhesion molecules, such as cadherin and n cadherin, through post-transcriptional modification of their mRNAs.

Despite its importance in cell adhesion and migration, CEACAMP10 is still a poorly understood gene. There are limited studies that have investigated the functions of CEACAMP10 in various organisms, and more research is needed to fully understand its role in these processes.

Potential Therapeutic Applications

The potential therapeutic applications of CEACAMP10 are vast, as it has been shown to play a critical role in various physiological processes. Here are some of the potential therapeutic applications of CEACAMP10:

1. Cancer Prevention and Treatment: CEACAMP10 has been shown to regulate the angiogenesis (the formation of new blood vessels) in various organisms, including humans. By inhibiting the activity of CEACAMP10, researchers have found that they can prevent the formation of new blood vessels, which can lead to the formation of tumors.
2. Tissue Regeneration: CEACAMP10 has been shown to regulate the production of new cells in various tissues, including the liver, pancreas, and skin. By activating the stem cell proliferation and tissue regeneration, CEACAMP10 has the potential to be used for tissue engineering and regeneration.
3. neurodegenerative diseases: CEACAMP10 has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. By targeting CEACAMP10, researchers have found that they can prevent the neurodegeneration that occurs in these diseases and potentially slow down or reverse the progression of the diseases.
4. Autoimmune diseases: CEACAMP10 has been shown to be involved in the development and progression of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. By targeting CEACAMP10, researchers have found that they can prevent the autoimmune response that occurs in these diseases and potentially reduce the severity of the response.

CEACAMP10 as a Biomarker

In addition to its potential therapeutic applications, CEACAMP10 may also be used as a biomarker for various diseases. Here are some of the potential biomarker applications of CEACAMP10:

1. Cancer: CEACAMP10 has been shown to be a potential biomarker for cancer, as it has been shown to be involved in the regulation of cancer cell adhesion and migration. By targeting CEACAMP10

Protein Name: CEA Cell Adhesion Molecule Pseudogene 10

The "CEACAMP10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CEACAMP10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets